MedPath
FDA Approval

PROCTOZONE-HC

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
May 7, 2023
Labeling Type
Human Prescription Drug Label
Hydrocortisone(25 mg in 1 g)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Lyne Laboratories, Inc.

Rising Pharma Holdings, Inc.

053510459

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PROCTOZONE-HC

Product Details

NDC Product Code
64980-324
Application Number
ANDA040879
Marketing Category
ANDA (C73584)
Route of Administration
TOPICAL
Effective Date
June 23, 2023
Code: WI4X0X7BPJClass: ACTIBQuantity: 25 mg in 1 g
WATERInactive
Code: 059QF0KO0RClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
GLYCERYL MONOSTEARATEInactive
Code: 230OU9XXE4Class: IACT
CHOLESTEROLInactive
Code: 97C5T2UQ7JClass: IACT
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJSClass: IACT
POLYSORBATE 60Inactive
Code: CAL22UVI4MClass: IACT
CETYL ALCOHOLInactive
Code: 936JST6JCNClass: IACT
METHYLPARABENInactive
Code: A2I8C7HI9TClass: IACT
SORBITAN MONOSTEARATEInactive
Code: NVZ4I0H58XClass: IACT
POLYOXYL 40 STEARATEInactive
Code: 13A4J4NH9IClass: IACT
SORBIC ACIDInactive
Code: X045WJ989BClass: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OHClass: IACT
© Copyright 2025. All Rights Reserved by MedPath